D Royston. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Aprotinin/administration & dosageAprotinin/adverse effectsBlood Coagulation/drug effectsBlood Coagulation/physiologyBlood Platelets/drug effectsCoronary Artery BypassCoronary Thrombosis/chemically inducedEndothelium, Vascular/drug effectsFibrinolysin/antagonists & inhibitorsFibrinolysis/drug effectsGraft Occlusion, Vascular/chemically inducedHemostasis/physiologyHumansIntraoperative Complications/chemically inducedMyocardial Infarction/chemically inducedRisk FactorsSafetySerine Proteinase Inhibitors/pharmacologyVascular Surgical ProceduresVeins/transplantation
Substances: See more » Serine Proteinase InhibitorsAprotininFibrinolysin
Year: 1994 PMID: 7515702 DOI: 10.1016/1053-0770(94)90050-7
Source DB: PubMed Journal: J Cardiothorac Vasc Anesth ISSN: 1053-0770 Impact factor: 2.628